Rights Issue22 Oct 2026, 06:30 pm
Natco Pharma: Trading Window Reopens Oct 23-28 for Rights Issue Allotment
AI Summary
Natco Pharma Ltd has announced the reopening of its trading window for Directors, Designated Persons, and connected individuals from October 23, 2026, to October 28, 2026. This window is specifically to facilitate the credit of Rights Equity shares into the demat accounts of allottees following the company's ongoing Rights Issue. The trading window was initially closed from October 1, 2026, until 48 hours after the declaration of the Unaudited Financial Results for the quarter ended September 30, 2026, in compliance with SEBI regulations.
Key Highlights
- Trading window reopens October 23-28 for specific persons.
- Facilitates credit of Rights Issue shares to demat accounts.
- Initial closure was for SEBI Insider Trading Regulations compliance.
- Rights Issue allotment process is currently underway.
Price Impact
More from NATCOPHARM